Cosmo Pharmaceuticals N.V. (SIX: COPN) (FSE: C43) (“Cosmo”) today announced a strategic Research and Development Agreement with Amsterdam UMC and Eindhoven University of Technology to develop and ...

Seaport Therapeutics ("Seaport" or the "Company"), a clinical-stage therapeutics company advancing novel neuropsychiatric medicines with a proven strategy and team, today announced the award of an up ...

The partnership pairs Novo Nordisk’s expertise in protein therapeutics with Vivtex’s gastrointestinal screening and formulation platform.

Background Congenital anomalies are among the common health problems faced by children in low- and middle-income countries, ...

Meet four CMU-affiliated startups that are translating academic research into tools that could improve health care for millions of Americans.

Theriva received a $300,000 upfront payment at signing and is eligible for up to $38M in development, regulatory, and sales milestones along with tiered single-digit royalties on net product sales - - ...

Recent technological advances have opened new possibilities for the development of advanced medical devices, including tiny ...

IRSF investment positions organization at the forefront of early-stage Rett research as genomic medicine reshapes rare ...

The growing prevalence of infectious diseases, increasing antimicrobial resistance (AMR), and the rising demand for rapid diagnostic solutions are the key drivers of growth in the global clinical ...

Aprofood combines specialty medical food ingredients and development services to provide technical support for FSMP ...

New research says that just one episode of binge drinking can impact the intestinal lining, causing “leaky gut” syndrome Getty Binge drinking can damage the lining of the intestine, allowing harmful ...